You are here

Recruiting Trials: Cord Blood

This portal enables our readers to find registered clinical trials worldwide that are currently enrolling patients for therapy with cord blood stem cells. If you are a patient seeking more information about a trial, please click on the link under the trial's registry identification. That will take you to the original trial registration, and within that description you should find contact information. This list does not constitute medical advice and Parent's Guide to Cord Blood Foundation has no relationship with any of these trial sponsors. We maintain this list by checking the world's largest clinical trial registries. We only display clinical studies that are registered on an official trials registry.

This web page was researched by Frances Verter, PhD, Alexey Bersenev, MD PhD, and Pedro Silva Couto, MSc ©2016-2017. Sources of clinical trials were searches of ClinicalTrials.gov, Chinese Clinical Trial Registry (ChiCTR), Japan University hospital Medical Information Network Clinical Trial Registry (UMIN-CTR), Japan Medical Association Clinical Trial Registry (JMA-CTR), Clinical Research Information Service from South Korea (CRiS), EU Clinical Trials Register (EudraCT), World Health Organization International Clinical Trials Registry Platform (ICTRP), Netherlands Trial Register (NTR), Australian New Zealand Clinical Trial Registry (ANZCTR), Clinical Trials Registry-India (CTRI), German Clinical Trials Register (DRKS), and Iranian Registry of Clinical Trials (IRCT).

Displaying 1 - 6 of 6 trials

Cerebral palsy (CP) is the most common physical disability in childhood. It is caused by damage to the developing brain either during pregnancy or shortly after birth. Read more about stem cell therapy for CP in our newsletters of March 2017, June 2016, March 2016, Sept. 2014, Feb. 2014, April 2012.

Trial registry: NCT01072370
Patient Ages Therapy Type Address
1 to 12 Autologous
  • Georgia Regents University
    1446 Harper St, Augusta, GA 30901, USA
    Stany Zjednoczone
Trial registry: NCT02866331
Patient Ages Therapy Type Address
2 to 10 Autologous
  • Hanyang University Hospital
    222-1 Wangsimni-ro, Sageun-dong, Seongdong-gu, Seoul
    Corea del Sur
Trial registry: NCT03130816
Patient Ages Therapy Type Address
10 mo to 20 yr Allogeneic
  • CHA Bundang Medical Center
    59 Yatap-ro, Bundang-gu, Seongnam, Gyeonggi-do
    Corea del Sur
Trial registry: NCT03327467
Patient Ages Therapy Type Address
up to 18 Allogeneic and/or Autologous
  • Duke University Medical Center
    Duke University Medical Center, 8 Duke University Medical Center Greenspace, Durham, NC 27703
    Stany Zjednoczone
Trial registry: NCT03352310
Patient Ages Therapy Type Address
up to 48 hrs Autologous
  • The Chinese University of Hong Kong
    Pond Cres, Ma Liu Shui, Hong Kong
    R.A.E. de Hong Kong, China
Trial registry: NCT03473301
Patient Ages Therapy Type Address
24 to 60 months Allogeneic
  • Duke University Medical Center
    2301 Erwin Rd, Durham, NC 27707, USA
    Estados Unidos